David Wambeke
Corporate Officer/Principal bij DIAMEDICA THERAPEUTICS INC.
Vermogen: 1 M $ op 30-04-2024
Profiel
David John Wambeke is currently the Chief Business Officer at DiaMedica Therapeutics, Inc. He previously worked as a Partner & Managing Director at Craig-Hallum Capital Group LLC.
He completed his undergraduate degree at the University of Minnesota.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
16-11-2023 | 527 114 ( 1.39% ) | 1 M $ | 30-04-2024 |
Actieve functies van David Wambeke
Bedrijven | Functie | Begin |
---|---|---|
DIAMEDICA THERAPEUTICS INC. | Corporate Officer/Principal | 11-04-2023 |
Eerdere bekende functies van David Wambeke
Bedrijven | Functie | Einde |
---|---|---|
Craig-Hallum Capital Group LLC
Craig-Hallum Capital Group LLC Investment Banks/BrokersFinance Craig-Hallum Capital Group LLC (Craig-Hallum) is an employee-owned, idea-driven research, trading and investment banking firm headquartered in Minneapolis, Minnesota. The firm was founded by Bradley Baker and Kevin Harris in 1997. Craig-Hallum provides research, institutional sales and trading and investment banking services to institutional investors and growth companies. | Analyst-Equity | 01-03-2023 |
Opleiding van David Wambeke
University of Minnesota | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
DIAMEDICA THERAPEUTICS INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Craig-Hallum Capital Group LLC
Craig-Hallum Capital Group LLC Investment Banks/BrokersFinance Craig-Hallum Capital Group LLC (Craig-Hallum) is an employee-owned, idea-driven research, trading and investment banking firm headquartered in Minneapolis, Minnesota. The firm was founded by Bradley Baker and Kevin Harris in 1997. Craig-Hallum provides research, institutional sales and trading and investment banking services to institutional investors and growth companies. | Finance |